Clinical Trials Directory

Trials / Unknown

UnknownNCT00305305

Brain Development Research Program

Disorders of Cerebral Development: A Phenotypic and Genetic Analysis

Status
Unknown
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
University of California, San Francisco · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Dr. Elliott Sherr and his collaborators at University of California, San Francisco (UCSF) are studying the genetic causes of disorders of cognition and epilepsy, in particular disorders of brain development that affect the corpus callosum, such as Aicardi syndrome, as well as two additional brain malformations, polymicrogyria and Dandy-Walker malformation. The goal of the investigators' research is to use a better understanding of the underlying genetic causes as a foundation to develop better treatments for these groups of patients.

Detailed description

We are studying both the genetics and clinical features of these disorders. We hope to understand the problems faced by individuals with these disorders as well as their causes. In the future, we hope to develop therapies that are geared specifically for individuals based on the underlying biology. To participate in the study, you will be asked to provide a copy of the magnetic resonance imaging (MRI) documenting Agenesis Corpus Callosum (ACC), Polymicrogyria (PMG), or Dandy-Walker malformation (DWM), clinical information, and saliva or blood samples from the affected individual and from the parents. Please see contact information and our webpage below.

Conditions

Timeline

Start date
2003-08-01
Primary completion
2025-01-01
Completion
2025-01-01
First posted
2006-03-21
Last updated
2023-10-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00305305. Inclusion in this directory is not an endorsement.